{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:15:36Z","timestamp":1794568536350,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Arthritis Foundation and Childhood Arthritis and Rheumatology Research Alliance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12969-019-0365-y","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T05:03:56Z","timestamp":1566968636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3357-4863","authenticated-orcid":false,"given":"Amer M.","family":"Khojah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa S.","family":"Klein-Gitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Hans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Pachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsay L.","family":"Fuleihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"issue":"2","key":"365_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","volume":"47","author":"GJ Weiner","year":"2010","unstructured":"Weiner GJ. Rituximab: mechanism of action. Semin Hematol. 2010;47(2):115\u201323.","journal-title":"Semin Hematol"},{"issue":"Suppl 2","key":"365_CR2","first-page":"S1","volume":"12","author":"DG Maloney","year":"2001","unstructured":"Maloney DG. Mechanism of action of rituximab. Anti-Cancer Drugs. 2001;12(Suppl 2):S1\u20134.","journal-title":"Anti-Cancer Drugs"},{"issue":"4","key":"365_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235\u201342.","journal-title":"N Engl J Med"},{"issue":"25","key":"365_CR4","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"JC Edwards","year":"2004","unstructured":"Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350(25):2572\u201381.","journal-title":"N Engl J Med"},{"issue":"6","key":"365_CR5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","volume":"4","author":"YT Becker","year":"2004","unstructured":"Becker YT, Becker BN, Pirsch JD, Sollinger HW. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant. 2004;4(6):996\u20131001.","journal-title":"Am J Transplant"},{"issue":"25","key":"365_CR6","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1182\/blood-2011-11-393975","volume":"119","author":"VL Patel","year":"2012","unstructured":"Patel VL, Mahevas M, Lee SY, Stasi R, Cunningham-Rundles S, Godeau B, et al. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood. 2012;119(25):5989\u201395.","journal-title":"Blood."},{"issue":"2","key":"365_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clml.2012.11.011","volume":"13","author":"C Casulo","year":"2013","unstructured":"Casulo C, Maragulia J, Zelenetz AD. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections. Clin Lymphoma Myeloma Leuk. 2013;13(2):106\u201311.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"365_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2014.11.009","volume":"57","author":"DM Roberts","year":"2015","unstructured":"Roberts DM, Jones RB, Smith RM, Alberici F, Kumaratne DS, Burns S, et al. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease. J Autoimmun. 2015;57:60\u20135.","journal-title":"J Autoimmun"},{"issue":"1","key":"365_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00431-006-0222-0","volume":"166","author":"G Bisogno","year":"2007","unstructured":"Bisogno G. Persistent B-cell depletion after rituximab for thrombocytopenic purpura. Eur J Pediatr. 2007;166(1):85\u20136.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"365_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/152581603321210082","volume":"12","author":"E Castagnola","year":"2003","unstructured":"Castagnola E, Dallorso S, Faraci M, Morreale G, Di Martino D, Cristina E, et al. Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy. J Hematother Stem Cell Res. 2003;12(1):9\u201310.","journal-title":"J Hematother Stem Cell Res"},{"issue":"9","key":"365_CR11","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1097\/TP.0b013e318188ac0c","volume":"86","author":"V Guerin","year":"2008","unstructured":"Guerin V, Yakouben K, Lescoeur B, Pedron B, Dalle JH, Baruchel A, et al. Prolonged agammaglobulinemia despite unaltered B-cell lymphopoiesis after peritransplant-rituximab administration in a child. Transplantation. 2008;86(9):1322\u20133.","journal-title":"Transplantation."},{"issue":"1","key":"365_CR12","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1542\/peds.2008-2361","volume":"123","author":"S Kumar","year":"2009","unstructured":"Kumar S, Benseler SM, Kirby-Allen M, Silverman ED. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Pediatrics. 2009;123(1):e159\u201363.","journal-title":"Pediatrics."},{"issue":"2","key":"365_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2249.2010.04206.x","volume":"162","author":"H Morbach","year":"2010","unstructured":"Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol. 2010;162(2):271\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"365_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","volume":"83","author":"RC Dale","year":"2014","unstructured":"Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology. 2014;83(2):142\u201350.","journal-title":"Neurology."},{"issue":"3","key":"365_CR15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1542\/peds.41.3.600","volume":"41","author":"RH Buckley","year":"1968","unstructured":"Buckley RH, Dees SC, O'Fallon WM. Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics. 1968;41(3):600\u201311.","journal-title":"Pediatrics."},{"issue":"1","key":"365_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1651-2227.1979.tb04424.x","volume":"68","author":"VA Oxelius","year":"1979","unstructured":"Oxelius VA. IgG subclass levels in infancy and childhood. Acta Paediatr Scand. 1979 Jan;68(1):23\u20137.","journal-title":"Acta Paediatr Scand"},{"issue":"1","key":"365_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4049\/jimmunol.176.1.165","volume":"176","author":"M Pihlgren","year":"2006","unstructured":"Pihlgren M, Friedli M, Tougne C, Rochat AF, Lambert PH, Siegrist CA. Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J Immunol. 2006;176(1):165\u201372.","journal-title":"J Immunol"},{"issue":"6","key":"365_CR18","first-page":"923","volume":"32","author":"JJ Haaijman","year":"1977","unstructured":"Haaijman JJ, Van Den Berg P, Brinkhof J. Immunoglobulin class and subclass levels in the serum of CBA mice throughout life. Immunology. 1977;32(6):923\u20137.","journal-title":"Immunology."},{"issue":"3","key":"365_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/iid3.26","volume":"2","author":"M Duchamp","year":"2014","unstructured":"Duchamp M, Sterlin D, Diabate A, et al. B-cell subpopulations in children: national reference values. Immun Inflamm Dis. 2014;2(3):131\u201340.","journal-title":"Immun Inflamm Dis"},{"issue":"5","key":"365_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037626","volume":"7","author":"N Venhoff","year":"2012","unstructured":"Venhoff N, Effelsberg NM, Salzer U, Warnatz K, Peter HH, Lebrecht D, et al. Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides. PLoS One. 2012;7(5):e37626.","journal-title":"PLoS One"},{"issue":"5","key":"365_CR21","first-page":"634","volume":"112","author":"S Mankarious","year":"1988","unstructured":"Mankarious S, Lee M, Fischer S, Pyun KH, Ochs HD, Oxelius VA, Wedgwood RJ. The half-lives of igg subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. J Lab Clin Med. 1988;112(5):634\u201340.","journal-title":"J Lab Clin Med"},{"issue":"3","key":"365_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00467-012-2361-z","volume":"28","author":"L Delbe-Bertin","year":"2013","unstructured":"Delbe-Bertin L, Aoun B, Tudorache E, Lapillone H, Ulinski T. Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome? Pediatr Nephrol. 2013;28(3):447\u201351.","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0365-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-019-0365-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0365-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T17:27:39Z","timestamp":1664213259000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-019-0365-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["365"],"URL":"https:\/\/doi.org\/10.1186\/s12969-019-0365-y","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"7 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is an IRB approved study (IRB# 2015\u2013333).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The final manuscript has been seen and approved for publication by all the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}